Journal article

Practical management of patients on apixaban: a consensus guide.

Christopher Ward, Greg Conner, Geoffrey Donnan, Alexander Gallus, Simon McRae

Thrombosis Journal | Published : 2013

Abstract

BACKGROUND: Atrial fibrillation (AF) is a common tachyarrhythmia in Australia, with a prevalence over 10% in older patients. AF is the leading preventable cause of ischaemic stroke, and strokes due to AF have a higher mortality and morbidity. Stroke prevention is therefore a key management strategy for AF patients, in addition to rate and rhythm control. Anticoagulation with warfarin has been an enduring gold standard for stroke prevention in NVAF patients. In Australia, three novel oral anticoagulants (NOACs), apixaban, dabigatran and rivaroxaban are now approved and reimbursed for stroke prevention in patients with non-valvular AF (NVAF). International European Cardiology guidelines now re..

View full abstract

Citation metrics